AAAAAA

   
Results: 1-11 |
Results: 11
LOW-DOSE ORAL IRON-ABSORPTION TEST - ESTABLISHMENT OF A REFERENCE INTERVAL
Authors: JENSEN NM BRANDSBORG M BOESEN AM YDE H DAHLERUP JF
Citation: Nm. Jensen et al., LOW-DOSE ORAL IRON-ABSORPTION TEST - ESTABLISHMENT OF A REFERENCE INTERVAL, Scandinavian journal of clinical & laboratory investigation, 58(6), 1998, pp. 511-519
LONG-TERM SURVIVAL AND DEVELOPMENT OF SECONDARY MALIGNANCIES IN PATIENTS WITH ACUTE MYELOID-LEUKEMIA TREATED WITH ACLARUBICIN OR DAUNORUBICIN PLUS CYTOSINE-ARABINOSIDE FOLLOWED BY INTENSIVE CONSOLIDATION CHEMOTHERAPY IN A DANISH NATIONAL PHASE-III TRIAL
Authors: BROWN PD HOFFMANN T HANSEN OP BOESEN AM GRONBAEK K HIPPE E JENSEN MK THORLING K STORM HH PEDERSENBJERGAARD J
Citation: Pd. Brown et al., LONG-TERM SURVIVAL AND DEVELOPMENT OF SECONDARY MALIGNANCIES IN PATIENTS WITH ACUTE MYELOID-LEUKEMIA TREATED WITH ACLARUBICIN OR DAUNORUBICIN PLUS CYTOSINE-ARABINOSIDE FOLLOWED BY INTENSIVE CONSOLIDATION CHEMOTHERAPY IN A DANISH NATIONAL PHASE-III TRIAL, Leukemia, 11(1), 1997, pp. 37-41
EXPERIMENTAL APPROACH TO THE SELECTION OF MONOCLONAL-ANTIBODIES (MOABS) FOR THERAPY OF B-CELL MALIGNANCIES
Authors: PULCZYNSKI S BOESEN AM JENSEN OM
Citation: S. Pulczynski et al., EXPERIMENTAL APPROACH TO THE SELECTION OF MONOCLONAL-ANTIBODIES (MOABS) FOR THERAPY OF B-CELL MALIGNANCIES, Experimental hematology, 25(8), 1997, pp. 553-553
LOW-DOSE IRON-ABSORPTION TEST - ESTABLISHMENT OF A REFERENCE INTERVAL
Authors: JENSEN NM BRANDSBORG M BOESEN AM YDE H DAHLERUP JF
Citation: Nm. Jensen et al., LOW-DOSE IRON-ABSORPTION TEST - ESTABLISHMENT OF A REFERENCE INTERVAL, Gut, 41, 1997, pp. 220-220
OUTCOME FOR PATIENTS WITH LEUKEMIA, MULTIPLE-MYELOMA AND LYMPHOMA WHORELAPSE AFTER HIGH-DOSE THERAPY AND AUTOLOGOUS STEM-CELL SUPPORT
Authors: JOHNSEN HE BJORKSTRAND B CARLSON K GRUBER A BLYSTAD A FAST A BOESEN AM BJORKHOLM M SALLERFORS B RUUTU T CARNESKOG J MALM A GEISLER C LEHTINEN M SCHRODER H BRINCH L REMES K TIDEFELT U HEILMANN C HORNSTEN P THORLING K DAUGAARD G
Citation: He. Johnsen et al., OUTCOME FOR PATIENTS WITH LEUKEMIA, MULTIPLE-MYELOMA AND LYMPHOMA WHORELAPSE AFTER HIGH-DOSE THERAPY AND AUTOLOGOUS STEM-CELL SUPPORT, Leukemia & lymphoma, 24(1-2), 1996, pp. 81-91
THE EFFECT OF IRON CHELATION ON HEMATOPOIESIS IN MDS PATIENTS WITH TRANSFUSIONAL IRON OVERLOAD
Authors: JENSEN PD HEICKENDORFF L PEDERSEN B BENDIXHANSEN K JENSEN FT CHRISTENSEN T BOESEN AM ELLEGAARD J
Citation: Pd. Jensen et al., THE EFFECT OF IRON CHELATION ON HEMATOPOIESIS IN MDS PATIENTS WITH TRANSFUSIONAL IRON OVERLOAD, British Journal of Haematology, 94(2), 1996, pp. 288-299
CLINICOPATHOLOGICAL FEATURES, SURVIVAL AND PROGNOSTIC FACTORS OF PRIMARY CENTRAL-NERVOUS-SYSTEM LYMPHOMAS - TRENDS IN INCIDENCE OF PRIMARY CENTRAL-NERVOUS-SYSTEM LYMPHOMAS AND PRIMARY MALIGNANT BRAIN-TUMORS INA WELL-DEFINED GEOGRAPHICAL AREA - POPULATION-BASED DATA FROM THE DANISH LYMPHOMA REGISTRY, LYFO, AND THE DANISH CANCER REGISTRY
Authors: KROGHJENSEN M DAMORE F JENSEN MK CHRISTENSEN BE THORLING K PEDERSEN M JOHANSEN P BOESEN AM ANDERSEN E
Citation: M. Kroghjensen et al., CLINICOPATHOLOGICAL FEATURES, SURVIVAL AND PROGNOSTIC FACTORS OF PRIMARY CENTRAL-NERVOUS-SYSTEM LYMPHOMAS - TRENDS IN INCIDENCE OF PRIMARY CENTRAL-NERVOUS-SYSTEM LYMPHOMAS AND PRIMARY MALIGNANT BRAIN-TUMORS INA WELL-DEFINED GEOGRAPHICAL AREA - POPULATION-BASED DATA FROM THE DANISH LYMPHOMA REGISTRY, LYFO, AND THE DANISH CANCER REGISTRY, Leukemia & lymphoma, 19(3-4), 1995, pp. 223-233
INCIDENCE, CLINICOPATHOLOGICAL FEATURES AND OUTCOME OF PRIMARY CENTRAL-NERVOUS-SYSTEM LYMPHOMAS - POPULATION-BASED DATA FROM A DANISH LYMPHOMA REGISTRY
Authors: KROGHJENSEN M DAMORE F JENSEN MK CHRISTENSEN BE THORLING K PEDERSEN M JOHANSEN P BOESEN AM ANDERSEN E
Citation: M. Kroghjensen et al., INCIDENCE, CLINICOPATHOLOGICAL FEATURES AND OUTCOME OF PRIMARY CENTRAL-NERVOUS-SYSTEM LYMPHOMAS - POPULATION-BASED DATA FROM A DANISH LYMPHOMA REGISTRY, Annals of oncology, 5(4), 1994, pp. 349-354
GM-CSF TREATMENT OF A PATIENT WITH HAIRY-CELL LEUKEMIA - A POTENTIALLY EFFECTIVE TREATMENT
Authors: PETERSLUND NA BOESEN AM
Citation: Na. Peterslund et Am. Boesen, GM-CSF TREATMENT OF A PATIENT WITH HAIRY-CELL LEUKEMIA - A POTENTIALLY EFFECTIVE TREATMENT, European journal of haematology, 53(4), 1994, pp. 249-250
MODULATION AND INTRACELLULAR-TRANSPORT OF CD20 AND CD21 ANTIGENS INDUCED BY B1 AND B2 MONOCLONAL-ANTIBODIES IN RAJI AND JOK-1 CELLS - AN IMMUNOFLUORESCENCE AND IMMUNOELECTRON MICROSCOPY STUDY
Authors: PULCZYNSKI S BOESEN AM JENSEN OM
Citation: S. Pulczynski et al., MODULATION AND INTRACELLULAR-TRANSPORT OF CD20 AND CD21 ANTIGENS INDUCED BY B1 AND B2 MONOCLONAL-ANTIBODIES IN RAJI AND JOK-1 CELLS - AN IMMUNOFLUORESCENCE AND IMMUNOELECTRON MICROSCOPY STUDY, Leukemia research, 18(7), 1994, pp. 541-552
INCIDENCE, PRESENTING FEATURES AND PROGNOSIS OF LOW-GRADE B-CELL NON-HODGKINS-LYMPHOMAS - POPULATION-BASED DATA FROM A DANISH LYMPHOMA REGISTRY
Authors: DAMORE F CHRISTENSEN BE THORLING K PEDERSEN M JENSEN MK BOESEN AM ANDERSEN E JOHANSEN P MORTENSEN LS
Citation: F. Damore et al., INCIDENCE, PRESENTING FEATURES AND PROGNOSIS OF LOW-GRADE B-CELL NON-HODGKINS-LYMPHOMAS - POPULATION-BASED DATA FROM A DANISH LYMPHOMA REGISTRY, Leukemia & lymphoma, 12(1-2), 1993, pp. 69-77
Risultati: 1-11 |